Pregnancy related acute myocardial infarction: Current trends in treatment and future prospects
1 Department of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2 Department of Health Sciences, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
3 Department of Obstetrics and Gynecology, General Hospital of Trikala, Trikala, Greece.
Review Article
World Journal of Advanced Research and Reviews, 2022, 16(02), 755-760
Publication history:
Received on 11 October 2022; revised on 18 November 2022; accepted on 21 November 2022
Abstract:
Acute myocardial infarction in pregnant women is an uncommon but potentially devastating complication with significantly increased rates of maternal and perinatal morbidity and mortality. The treatment of acute coronary syndrome in pregnancy is a unique clinical challenge. Published data on the use of thrombolytic drugs, percutaneous coronary intervention, coronary artery bypass grafting and optimal medical management of ischemic heart disease in pregnancy are limited. This article attempts to review acute myocardial infarction in pregnancy, regarding the basic treatment principles, the timely and correct application of which can yield the best possible result for the mother and the fetus and the newborn.
Keywords:
Medication; Thrombolysis; Percutaneous Coronary Intervention; Coronary Atrery Bapyss Grafting
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0